Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection
2017
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Linkage Map ofEscherichia coliK-12, Edition 10: The Traditional Map
1998
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
The COG database: an updated version includes eukaryotes
2003 Standout
Reconstitution of the DNA base excision—repair pathway
1994 StandoutNobel
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
CLINICAL RELEVANCE OF ANTIFUNGAL RESISTANCE
1997
Phylogenetic Species Recognition and Species Concepts in Fungi
2000 Standout
Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing
1996
REPuter: the manifold applications of repeat analysis on a genomic scale
2001 Standout
Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp. APS
2000 StandoutNature
Clinical Utility of Cytomegalovirus (CMV) Serology Testing in High-risk CMV D+/R- Transplant Recipients
2005
Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans
2002
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
2015
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
2003
Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
1996
Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans
2011
Horizontal gene transfer in eukaryotic evolution
2008 Standout
Identification of new loci involved in adhesion of Listeria monocytogenes to eukaryotic cells The GenBank accession numbers for the sequences determined in this work are AF104224–AF104229.
2000
Enzymic release of 5'-terminal deoxyribose phosphate residues from damaged DNA in human cells
1991 StandoutNobel
Echinocandin antifungal drugs
2003 Standout
DNA Damage and Oxygen Radical Toxicity
1988 StandoutScience
How were new medicines discovered?
2011 Standout
Recent Evolution of the Human Pathogen Cryptococcus neoformans by Intervarietal Transfer of a 14-Gene Fragment
2006
Amphotericin B as Primary Therapy for Cryptococcosis in Patients with AIDS: Reliability of Relatively High Doses Administered over a Relatively Short Period
1995
A new mechanism for repairing oxidative damage to DNA: (A)BC excinuclease removes AP sites and thymine glycols from DNA
1989 StandoutNobel
Raft-Like Membrane Domains in Pathogenic Microorganisms
2015
The mystery of membrane organization: composition, regulation and roles of lipid rafts
2017 Standout
The COG database: a tool for genome-scale analysis of protein functions and evolution
2000 Standout
Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: Strain variation in Cryptococcus neoformans
1995
Release of 5′-terminal deoxyribose-phosphate residues from incised abasic sites in DNA by theEscherichia coliRecJ protein
1994 StandoutNobel
In vitro and in vivo evaluation of antifungal agents
1989
Genome Alignment, Evolution of Prokaryotic Genome Organization, and Prediction of Gene Function Using Genomic Context
2001
Sputum Isolation of Wangiella dermatitidis in Patients with Cystic Fibrosis
2001
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Human DNA Damage Checkpoint Protein hRAD9 Is a 3′ to 5′ Exonuclease
2000 StandoutNobel
Immunity to fungal infections
2011 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Management and Prevention of Cytomegalovirus Infection After Renal Transplantation
1992
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism.
1994
Antifungal drug resistance
1995
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests
1992
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Peptide Antimicrobial Agents
2006 Standout
Functions of the gene products of Escherichia coli
1993
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice
1994
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Generation of Single-Nucleotide Repair Patches Following Excision of Uracil Residues from DNA
1992 StandoutNobel
Virulence factors of medically important fungi
1996
Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City
1994
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-α Release in Response to Cryptococcus neoformans Polysaccharide Capsule
2001
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin
1992
Combination Antifungal Therapy
2004
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli
1988
Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study
2006
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Endonuclease IV (nfo) mutant of Escherichia coli
1986
Compounds active against cell walls of medically important fungi
1993
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
1998
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Repair and Genetic Consequences of Endogenous DNA Base Damage in Mammalian Cells
2004 StandoutNobel
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
2018
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Evaluation of Gen-Probe's Histoplasma capsulatum and Cryptococcus neoformans AccuProbes
1993
Multiplex Polymerase Chain Reaction Tests for Detection of Pathogens Associated with Gastroenteritis
2015
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Karyotyping of Cryptococcus neoformans as an epidemiological tool
1993
Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection
2000
DNA deoxyribophosphodiesterase.
1988 StandoutNobel
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
1993
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B
1994
Short-Sequence DNA Repeats in Prokaryotic Genomes
1998
Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis
1991
Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans
1993
The Complete Genome Sequence of Escherichia coli K-12
1997 StandoutScience
Multilocus enzyme typing of Cryptococcus neoformans
1993
Antibody immunity and invasive fungal infections
1995
A Genomic Perspective on Protein Families
1997 StandoutScience
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid
1993
Molecular typing of Cryptococcus neoformans serotype D clinical isolates
1994
How Sweet it is! Cell Wall Biogenesis and Polysaccharide Capsule Formation in Cryptococcus neoformans
2009
Generation of single-nucleotide repair patches following excision of uracil residues from DNA.
1992 StandoutNobel
DNA probe for strain typing of Cryptococcus neoformans
1992
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei
1997
Drug Resistance in Leishmaniasis
2006 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro
1997
Antifungal Peptides: Novel Therapeutic Compounds against Emerging Pathogens
1999
Works of Eric D. Spitzer being referenced
MRSA Causing Infections in Hospitals in Greater Metropolitan New York: Major Shift in the Dominant Clonal Type between 1996 and 2014
2016
MRSA Rates and Antibiotic Susceptibilities from Skin and Soft Tissue Cultures in a Suburban ED
2012
Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates ofCandida species
1988
Rapid detection of Clostridium difficile in stool using the VIDASR C. difficile Toxin A II assay
2003
Temperature-Sensitive Variants of Histoplasma capsulatum Isolated from Patients with Acquired Immunodeficiency Syndrome
1990
Comparison of Culture and Serology for the Diagnosis of Cytomegalovirus Infection in Kidney and Liver Transplant Recipients
1990
Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone
2017
A multiplex PCR/LDR assay for simultaneous detection and identification of the NIAID category B bacterial food and water-borne pathogens
2014
Persistence of initial infection in recurrent Cryptococcus neoformans meningitis
1993
Characterization of the CNRE-1 family of repetitive DNA elements in Cryptococcus neoformans
1994
Testing of organisms for susceptibility to triazoles: Is it justified?
1989
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis
1995
DNA probe for the identification of Histoplasma capsulatum
1989
Catheter-associated fungemia due to Wangiella (Exophiala) dermatitidis
1996
Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans
1992
Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole
1993
Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1
1995
Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum
1989
dfp Gene of Escherichia coli K-12, a locus affecting DNA synthesis, codes for a flavoprotein
1985
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole
1994
beta-Alanine auxotrophy associated with dfp, a locus affecting DNA synthesis in Escherichia coli
1988